Search - tctmd.com

Displaying 121 - 140 of 146

Sort: Relevancy | Date

Cystatin C is superior diagnostic tool compared with conventional Serum Creatinine or Estimated Glomerular Filtration Rate in prediction of Contrast Induced Nephropathy.

Presentation TCT 2012

Cystatin C is superior diagnostic tool compared with conventional Serum Creatinine or Estimated Glomerular Filtration Rate in prediction of Contrast Induced Nephropathy.

Presenter: Hyuck Jun Yoon, Ji Hyun Sohn, Hong Won Shin, Ho Myung Lee, Hyun ok Cho, Hyoung-Seob Park, Yun-Kyeong Cho, Chang-Wook Nam, Hyungseop Kim, Seung Ho Hur, Yoon-Nyun Kim, Kwon Bae Kim

January 03, 2012

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Presentation TCT 2012

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Presenter: Norbert Mayaud, Karl Isaaz, Christophe Mariat, Alexis Cerisier, Michel Lamaud, Laure Richard, Antoine Da Costa

January 03, 2012

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Presentation TCT 2012

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Presenter: Hyuck Jun Yoon, Ji Hyun Sohn, Ho Myung Lee, Hyun ok Cho, Hong Won Shin, Yun-Kyeong Cho, Hyoung-Seob Park, Hyungseop Kim, Chang-Wook Nam, Seung Ho Hur, Yoon-Nyun Kim, Kwon Bae Kim

January 03, 2012

News Industry News

Echo May Not Provide Best Picture for TAVI

November 06, 2011

News Industry News

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

October 14, 2011

News Daily News

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

October 07, 2011

News Industry News

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

September 22, 2011

News Daily News

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

August 26, 2011

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

August 19, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

News Daily News

New Contrast Dosing Method Helps Avoid Nephropathy in PCI Patients

August 18, 2011

News Daily News

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

August 16, 2011

News Daily News

High Homocysteine Levels Linked with Contrast Nephropathy

July 28, 2011

News Daily News

Endovascular Intervention Generally Safe in Elderly PAD Patients

June 20, 2011

News Industry News

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 02, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

May 18, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

May 05, 2011

News Daily News

Women More Likely Than Men to Develop CIN after Angiography

April 29, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

April 08, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.